• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

预测计划进行根治性切除的肝门部胆管癌患者早期复发的机器学习模型:一项多中心研究

Machine learning model to predict early recurrence in patients with perihilar cholangiocarcinoma planned treatment with curative resection: a multicenter study.

作者信息

Wang Xiang, Liu Li, Liu Zhi-Peng, Wang Jiao-Yang, Dai Hai-Su, Ou Xia, Zhang Cheng-Cheng, Yu Ting, Liu Xing-Chao, Pang Shu-Jie, Fan Hai-Ning, Bai Jie, Jiang Yan, Zhang Yan-Qi, Wang Zi-Ran, Chen Zhi-Yu, Li Ai-Guo

机构信息

Department of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University (Army Medical University), Chongqing, China.

Department of Digital Medicine, School of Biomedical Engineering and Medical Imaging, Third Military Medical University (Army Medical University), Chongqing, China.

出版信息

J Gastrointest Surg. 2024 Dec;28(12):2039-2047. doi: 10.1016/j.gassur.2024.09.027. Epub 2024 Oct 3.

DOI:10.1016/j.gassur.2024.09.027
PMID:39368645
Abstract

BACKGROUND

Early recurrence is the leading cause of death for patients with perihilar cholangiocarcinoma (pCCA) after surgery. Identifying high-risk patients preoperatively is important. This study aimed to construct a preoperative prediction model for the early recurrence of patients with pCCA to facilitate planned treatment with curative resection.

METHODS

This study ultimately enrolled 400 patients with pCCA after curative resection in 5 hospitals between 2013 and 2019. They were randomly divided into training (n = 300) and testing groups (n = 100) at a ratio of 3:1. Associated variables were identified via least absolute shrinkage and selection operator (LASSO) regression. Four machine learning models were constructed: support vector machine, random forest (RF), logistic regression, and K-nearest neighbors. The predictive ability of the models was evaluated via receiving operating characteristic (ROC) curves, precision-recall curve (PRC) curves, and decision curve analysis. Kaplan-Meier (K-M) survival curves were drawn for the high-/low-risk population.

RESULTS

Five factors: carbohydrate antigen 19-9, tumor size, total bilirubin, hepatic artery invasion, and portal vein invasion, were selected by LASSO regression. In both the training and testing groups, the ROC curve (area under the curve: 0.983 vs 0.952) and the PRC (0.981 vs 0.939) showed that RF was the best. The cutoff value for distinguishing high- and low-risk patients was 0.51. K-M survival curves revealed that in both groups, there was a significant difference in RFS between high- and low-risk patients (P < .001).

CONCLUSION

This study used preoperative variables from a large, multicenter database to construct a machine learning model that could effectively predict the early recurrence of pCCA in patients to facilitate planned treatment with curative resection and help clinicians make better treatment decisions.

摘要

背景

早期复发是肝门部胆管癌(pCCA)患者术后死亡的主要原因。术前识别高危患者很重要。本研究旨在构建pCCA患者早期复发的术前预测模型,以促进根治性切除的计划性治疗。

方法

本研究最终纳入了2013年至2019年间在5家医院接受根治性切除的400例pCCA患者。他们以3:1的比例随机分为训练组(n = 300)和测试组(n = 100)。通过最小绝对收缩和选择算子(LASSO)回归确定相关变量。构建了四种机器学习模型:支持向量机、随机森林(RF)、逻辑回归和K近邻。通过接受操作特征(ROC)曲线、精确召回率曲线(PRC)和决策曲线分析评估模型的预测能力。为高/低风险人群绘制了Kaplan-Meier(K-M)生存曲线。

结果

通过LASSO回归选择了五个因素:糖类抗原19-9、肿瘤大小、总胆红素、肝动脉侵犯和门静脉侵犯。在训练组和测试组中,ROC曲线(曲线下面积:0.983对0.952)和PRC(0.981对0.939)均显示RF是最佳模型。区分高风险和低风险患者的临界值为0.51。K-M生存曲线显示,在两组中,高风险和低风险患者之间无复发生存期(RFS)存在显著差异(P <.001)。

结论

本研究使用来自大型多中心数据库的术前变量构建了一个机器学习模型,该模型可以有效预测pCCA患者的早期复发,以促进根治性切除的计划性治疗,并帮助临床医生做出更好的治疗决策。

相似文献

1
Machine learning model to predict early recurrence in patients with perihilar cholangiocarcinoma planned treatment with curative resection: a multicenter study.预测计划进行根治性切除的肝门部胆管癌患者早期复发的机器学习模型:一项多中心研究
J Gastrointest Surg. 2024 Dec;28(12):2039-2047. doi: 10.1016/j.gassur.2024.09.027. Epub 2024 Oct 3.
2
Establishment and validation of a prognostic nomogram for patients with resectable perihilar cholangiocarcinoma.可切除性肝门部胆管癌患者预后列线图的建立与验证
Oncotarget. 2016 Jun 14;7(24):37319-37330. doi: 10.18632/oncotarget.9104.
3
Residual biliary intraepithelial neoplasia without malignant transformation at resection margin for perihilar cholangiocarcinoma does not require expanded resection: a dual center retrospective study.肝门周围胆管癌切缘残留无恶性转化的胆管上皮内瘤变不需要扩大切除:一项双中心回顾性研究。
World J Surg Oncol. 2024 Jun 21;22(1):161. doi: 10.1186/s12957-024-03395-5.
4
Differences in Prognostic Factors and Recurrence Patterns After Curative-Intent Resection of Perihilar and Distal Cholangiocarcinomas.肝门部胆管癌和远端胆管癌根治性切除术后预后因素及复发模式的差异
Scand J Surg. 2020 Sep;109(3):219-227. doi: 10.1177/1457496919832150. Epub 2019 Feb 21.
5
Concomitant hepatic artery resection for advanced perihilar cholangiocarcinoma: a case-control study with propensity score matching.晚期肝门部胆管癌同期肝动脉切除术:一项倾向评分匹配的病例对照研究
J Hepatobiliary Pancreat Sci. 2016 Jul;23(7):442-8. doi: 10.1002/jhbp.363. Epub 2016 Jun 9.
6
Lymphocyte to Monocyte Ratio Predicts Resectability and Early Recurrence of Bismuth-Corlette Type IV Hilar Cholangiocarcinoma.淋巴细胞与单核细胞比值预测可切除性和毕氏Ⅳ型肝门胆管癌早期复发。
J Gastrointest Surg. 2020 Feb;24(2):330-340. doi: 10.1007/s11605-018-04086-9. Epub 2019 Jan 22.
7
Preoperative factors predicting outcomes in patients with suspected perihilar cholangiocarcinoma referred for curative resection- a single-center 10-year experience.预测接受根治性切除术的疑似肝门部胆管癌患者预后的术前因素——单中心10年经验
Langenbecks Arch Surg. 2024 Dec 21;410(1):13. doi: 10.1007/s00423-024-03583-7.
8
Surgical Outcomes for Perihilar Cholangiocarcinoma with Vascular Invasion.肝门部胆管癌伴血管侵犯的手术治疗结果。
J Gastrointest Surg. 2019 Jul;23(7):1443-1453. doi: 10.1007/s11605-018-3948-x. Epub 2018 Sep 10.
9
Survival analysis of patients with stage T2a and T2b perihilar cholangiocarcinoma treated with radical resection.T2a 和 T2b 肝门周围胆管癌根治性切除术后患者的生存分析。
BMC Cancer. 2020 Sep 3;20(1):849. doi: 10.1186/s12885-020-07357-4.
10
Long-term outcome and prognostic factors of intrahepatic cholangiocarcinoma involving the hepatic hilus versus hilar cholangiocarcinoma after curative-intent resection: Should they be recognized as perihilar cholangiocarcinoma or differentiated?肝门部胆管癌累及肝门部与肝门部胆管癌根治性切除术后的长期预后和预后因素:是否应将其视为肝门周围胆管癌或加以区分?
Eur J Surg Oncol. 2019 Nov;45(11):2173-2179. doi: 10.1016/j.ejso.2019.06.014. Epub 2019 Jun 11.